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A high degree of diversity of Mycobacterium
tuberculosis has been shown with restriction
fragment length polymorphism (RFLP) typing
using IS6110 as a probe, particularly in countries
like the Netherlands, where many tuberculosis
(TB) cases occur among immigrants (1).
However, in the Beijing region of China, a
particular genotype was found in >80% of the TB
patients and was thus designated the Beijing
genotype (2). In other parts of China and in Asian
countries such as Mongolia, Thailand, and Korea,
40% to 50% of the tested M. tuberculosis isolates
represented this genotype (2). Although Beijing
genotype strains carry a large number of IS6110
insertion elements, the IS6110 RFLP patterns
are highly similar (2). Moreover, the
spoligopatterns of Beijing genotype strains are
identical and distinct from those of other
M. tuberculosis strains (1), which suggests that
strains of the Beijing genotype have emerged
recently from a single ancestor.
Reasons for the predominance of a narrow
range of genotypes may include limited contact
with other populations or a selective advantage of
certain strains due to reduced sensitivity to
vaccine-induced immunity. For instance, wide-
scale application of vaccines against whooping
cough (Bordetella pertussis) has led to shifts in
the populations of circulating pathogens (3). BCG
vaccination, which has been applied widely in
China since the early 1950s, may have led to a
similar shift in the population of M. tuberculosis.
Alternatively, a selective advantage may be
provided by reduced sensitivity to anti-TB drugs.
The Beijing genotype was associated with recent
transmission of drug-resistant strains in Cuba,
Germany, Russia, and Estonia (4-7). The largest
known epidemic of multidrug-resistant TB in
North America was caused by the “W” strain, a
variant of the Beijing genotype (8).
Vietnam is one of 22 countries in which 80%
of the world’s new TB cases occur (9). Among
these 22 countries, Vietnam has one of the most
successful directly observed therapy short-
course programs, with a cure rate of approxi-
mately 90% and a case-detection rate estimated
at 67% in 1996 and at >70% since then (National
Tuberculosis Programme, unpub. data). BCG
coverage has been high (>80%) during the past
decade, and the level of primary multidrug
resistance was recently estimated at 2.3% (9,10).
We investigated the spread of M. tuberculosis
Beijing genotype strains in Vietnam and whether
the spread is associated with BCG vaccination
status or drug resistance.
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To assess whether the Mycobacterium tuberculosis Beijing genotype is emerging in
Vietnam, we analyzed 563 isolates from new cases by spoligotyping and examined the
association between the genotype and age, resistance, and BCG vaccination status.
Three hundred one (54%) patients were infected with Beijing genotype strains. The
genotype was associated with younger age (and hence with active transmission) and
with isoniazid and streptomycin resistance, but not with BCG vaccination.Dispatches Dispatches Dispatches Dispatches Dispatches
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Table 1. Beijing genotype of Mycobacterium tuberculosis in 563 new tuberculosis cases, by age and BCG status, in
Hanoi and Ho Chi Minh City, Vietnam, 1998
Beijing genotype              ORa (95% CIb)
No. No. (%) Crude Adjustedc
Province
Hanoi   64   37 (58) 1 (p>0.05)
Ho Chi Minh City 499 264 (53) 0.8 (0.5-1.4)
Age group
<25   76   54 (71) 1 (p<0.001) 1
25-34 173 102 (59) 0.6 (0.3-1.0) 0.6 (0.3-1.1)
35-44 164   83 (51) 0.4 (0.2-0.7) 0.4 (0.2-0.8)
45-54   74   31 (42) 0.3 (0.1-0.6) 0.3 (0.2-0.6)
55-64   39   16 (41) 0.3 (0.1-0.6) 0.3 (0.1-0.7)
65+   37   15 (41) 0.3 (0.1-0.6) 0.3 (0.1-0.7)
BCG scar
Yes 285 167 (59) 1(p<0.05) 1
No 278 134 (48) 0.7 (0.5-0.9) 0.9 (0.6-1.3)
Total 563 301 (54)
aOR, odds ratio.
bCI, confidence interval.
cAdjusted for age and BCG vaccination.
Figure. Representative spoligotype patterns of the
Beijing (A) and the Vietnam (B) genotypes. Numbers
indicate the spacer oligonucleotide sequences, present
on the reversed line blot, which are derived from
reference Mycobacterium tuberculosis strain H37Rv
and M. bovis BCG vaccine strain P3.
In total, 822 isolates were obtained from TB
patients whose age and BCG status were known.
Of these, 563 had newly diagnosed disease (Table
1). The isolates were collected in 1998 and the
first quarter of 1999 at the Tuberculosis and
Lung Diseases Centre in Ho Chi Minh City and
the National Institute of Tuberculosis and
Respiratory Diseases in Hanoi, respectively. The
isolates were analyzed by spoligotyping (11). In
spoligotyping, the genomic direct repeat (DR)
region of M. tuberculosis complex bacteria is
amplified by polymerase chain reaction (PCR)
and the presence of 43 spacer sequences between
the DRs is examined in a reversed line-blot assay
(2,11). In previous studies, this method has
proven highly reliable for distinguishing Beijing
genotype strains (2). Among the 563
spoligopatterns analyzed, two predominant
genotypes were recognized (Figure), of which the
Beijing type was the most frequent (n = 301;
53%). The second most frequent genotype was not
found in the database of spoligopatterns of 2,500
M. tuberculosis isolates from countries all over
the world, held at the National Institute of Public
Health and the Environment in Bilthoven and
designated Vietnam genotype (n = 152; 27%)
(Figure). The remaining 110 isolates exhibited 18
different spoligopatterns.
The Beijing genotype was strongly associated
with younger age (Χ  2
trend; p <0.001), but not with
BCG status, after the data were adjusted for age
(Table 1). As levels of drug resistance varied
between Hanoi and Ho Chi Minh City and the
number of samples from Hanoi was small, the
association of the Beijing genotype and drug
resistance was restricted to Ho Chi Minh City
(Table 2). Drug resistance was found more
commonly in the Beijing than in other genotypes
(Table 2). The association with drug resistance
was significant for isoniazid (OR 1.7; 95% CI 1.1-
2.6) and streptomycin (odds ratio [OR] 3.1; 95%
confidence interval [CI] 2.0-4.6) resistance.
TB occurs partly as primary disease
(typically defined as occurring within 5 years of
infection) and partly as endogenous reactivation
or exogenous reinfection (occurring >5 yearsDispatches Dispatches Dispatches Dispatches Dispatches
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Table 2. Risk factors for drug resistance in 499 new tuberculosis cases in Ho Chi Minh City
Resistance (%) ORa (95% CIb)
 No. INH SM RIF EMB MDR INH SM
Genotype
Beijing 264 28 42 3 3 3 1.7 (1.1-2.6) 3.1 (2.0-4.6)
Other 235 19 19 2 1 2 1 (p<0.05) 1 (p<0.001)
Age group
<25   66 17 36 3 0 3 1 (p>0.05) 1 (p>0.05)
25-34 165 27 32 3 2 3 1.8 (0.9-3.8) 0.8 (0.4-1.5)
35-44 147 25 33 1 1 1 1.7 (0.8-3.5) 0.8 (0.5-1.6)
45-54   59 19 25 3 5 3 1.1 (0.5-2.9) 0.6 (0.3-1.3)
55-64   30 23 23 3 3 3 1.5 (0.5-4.4) 0.5 (0.2-1.4)
65+   32 31 31 0 0 0 2.3 (0.8-6.1) 0.8 (0.3-2.0)
BCG scar
Yes 259 22 31 3 2 3 1 (p>0.05) 1 (p>0.05)
No 402 73 22 2 2 2 1.3 (0.9-2.0) 1.1 (0.7-1.6)
Total 499 24 31 2 2 2
aOR, odds ratio.
bCI, confidence interval.
INH, isoniazide; SM, streptomycin; RIF, rifampin; EMB, ethambutol; MDR, multidrug resistant
after infection). With increasing age, a decreas-
ing proportion of cases is due to primary TB.
Thus, the association of the Beijing genotype and
young age suggests a recent spread of the Beijing
genotype in Vietnam. The study of Qian et al., in
which spoligotyping was performed on paraffin-
embedded material, indicated that the Beijing
genotype was presumably already prevalent in
the Beijing region 30 to 40 years ago (12).
In Vietnam, the Beijing genotype occurs more
commonly in those with a BCG scar than in those
without it. However, this is likely to represent a
cohort effect of BCG vaccination, rather than
reduced sensitivity to vaccine-induced immunity
of Beijing genotype strains. Because of increasing
BCG vaccination coverage in Vietnam over the
past 2 decades, young people are more likely to be
vaccinated than older people. Within age groups,
occurrence of the Beijing genotype is not
associated with BCG vaccination status.
Its striking association with anti-TB drug
resistance may explain the Beijing genotype’s
predominance in recently infected patients. Anti-
TB drugs are widely used in Vietnam, and anti-
TB drug resistance would thus provide a selective
advantage. In vitro experiments should deter-
mine whether Beijing genotype strains have an
increased intrinsic resistance to anti-TB drugs or
an enhanced capacity to gain resistance against
these drugs.
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